To identify the molecular link between Plcγ2 and AD, Christian Haass and colleagues generated a Plcγ2-P522R knock-in mouse model using CRISPR-Cas9 and found that this variant may reduce the risk of AD by increasing microglial function [54]. This evidence concerns the gene PLCG2 and Alzheimer disease.